Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 17 studies | 38% ± 18% | |
endothelial cell | 17 studies | 34% ± 15% | |
fibroblast | 16 studies | 32% ± 16% | |
oligodendrocyte precursor cell | 13 studies | 49% ± 18% | |
oligodendrocyte | 13 studies | 40% ± 16% | |
microglial cell | 13 studies | 34% ± 13% | |
GABAergic neuron | 11 studies | 44% ± 25% | |
glutamatergic neuron | 11 studies | 55% ± 25% | |
pericyte | 10 studies | 36% ± 18% | |
adipocyte | 8 studies | 40% ± 13% | |
smooth muscle cell | 8 studies | 31% ± 10% | |
epithelial cell | 7 studies | 30% ± 13% | |
interneuron | 6 studies | 56% ± 26% | |
macrophage | 6 studies | 36% ± 12% | |
endothelial cell of lymphatic vessel | 6 studies | 37% ± 13% | |
neuron | 5 studies | 47% ± 13% | |
type I pneumocyte | 5 studies | 27% ± 8% | |
type II pneumocyte | 5 studies | 26% ± 7% | |
plasma cell | 4 studies | 23% ± 6% | |
cardiac muscle cell | 4 studies | 17% ± 1% | |
mast cell | 4 studies | 21% ± 4% | |
mesothelial cell | 4 studies | 33% ± 8% | |
ciliated cell | 4 studies | 20% ± 6% | |
amacrine cell | 4 studies | 34% ± 13% | |
retina horizontal cell | 4 studies | 36% ± 16% | |
club cell | 4 studies | 27% ± 9% | |
GABAergic interneuron | 3 studies | 47% ± 5% | |
granule cell | 3 studies | 29% ± 13% | |
progenitor cell | 3 studies | 35% ± 4% | |
vein endothelial cell | 3 studies | 33% ± 20% | |
GABAergic amacrine cell | 3 studies | 36% ± 13% | |
Mueller cell | 3 studies | 31% ± 11% | |
glycinergic amacrine cell | 3 studies | 35% ± 12% | |
retinal ganglion cell | 3 studies | 41% ± 18% | |
retinal rod cell | 3 studies | 21% ± 0% | |
endothelial cell of vascular tree | 3 studies | 31% ± 18% | |
hepatocyte | 3 studies | 46% ± 25% | |
retinal pigment epithelial cell | 3 studies | 36% ± 23% | |
connective tissue cell | 3 studies | 36% ± 5% | |
ependymal cell | 3 studies | 40% ± 17% | |
alveolar macrophage | 3 studies | 24% ± 6% | |
monocyte | 3 studies | 22% ± 0% | |
respiratory goblet cell | 3 studies | 30% ± 10% | |
basal cell | 3 studies | 36% ± 19% | |
transit amplifying cell | 3 studies | 38% ± 27% | |
mucus secreting cell | 3 studies | 26% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 2117.81 | 459 / 459 | 100% | 11.96 | 1116 / 1118 |
bladder | 100% | 1850.00 | 21 / 21 | 99% | 11.33 | 500 / 504 |
prostate | 100% | 1488.32 | 244 / 245 | 100% | 9.14 | 500 / 502 |
lung | 99% | 1507.82 | 575 / 578 | 100% | 8.84 | 1151 / 1155 |
stomach | 100% | 1229.11 | 359 / 359 | 99% | 10.58 | 283 / 286 |
uterus | 100% | 2152.79 | 170 / 170 | 99% | 9.46 | 454 / 459 |
pancreas | 100% | 1165.32 | 328 / 328 | 99% | 10.17 | 176 / 178 |
esophagus | 99% | 1360.86 | 1426 / 1445 | 99% | 9.31 | 182 / 183 |
intestine | 100% | 1325.87 | 966 / 966 | 98% | 10.40 | 517 / 527 |
kidney | 100% | 1205.96 | 89 / 89 | 98% | 8.97 | 883 / 901 |
adrenal gland | 100% | 1396.81 | 258 / 258 | 98% | 7.32 | 225 / 230 |
ovary | 100% | 1795.04 | 180 / 180 | 97% | 5.62 | 417 / 430 |
thymus | 100% | 2079.97 | 653 / 653 | 96% | 11.02 | 582 / 605 |
skin | 98% | 1732.76 | 1777 / 1809 | 96% | 12.18 | 451 / 472 |
liver | 92% | 614.81 | 209 / 226 | 94% | 5.36 | 381 / 406 |
brain | 86% | 806.61 | 2262 / 2642 | 100% | 8.38 | 704 / 705 |
adipose | 100% | 2221.87 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3300.21 | 1335 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 5.51 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.27 | 1 / 1 |
spleen | 99% | 801.72 | 239 / 241 | 0% | 0 | 0 / 0 |
heart | 96% | 1138.82 | 827 / 861 | 0% | 0 | 0 / 0 |
muscle | 77% | 478.52 | 615 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 74% | 5.19 | 59 / 80 |
lymph node | 0% | 0 | 0 / 0 | 62% | 2.20 | 18 / 29 |
peripheral blood | 19% | 255.13 | 173 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0018279 | Biological process | protein N-linked glycosylation via asparagine |
GO_0097359 | Biological process | UDP-glucosylation |
GO_0036503 | Biological process | ERAD pathway |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005793 | Cellular component | endoplasmic reticulum-Golgi intermediate compartment |
GO_0003980 | Molecular function | UDP-glucose:glycoprotein glucosyltransferase activity |
GO_0005515 | Molecular function | protein binding |
GO_0051082 | Molecular function | unfolded protein binding |
Gene name | UGGT2 |
Protein name | UDP-glucose:glycoprotein glucosyltransferase 2 (UGT2) (hUGT2) (EC 2.4.1.-) (UDP--Glc:glycoprotein glucosyltransferase 2) (UDP-glucose ceramide glucosyltransferase-like 1) UDP-glucose glycoprotein glucosyltransferase 2 |
Synonyms | UGCGL2 UGT2 |
Description | FUNCTION: Recognizes glycoproteins with minor folding defects. Reglucosylates single N-glycans near the misfolded part of the protein, thus providing quality control for protein folding in the endoplasmic reticulum. Reglucosylated proteins are recognized by calreticulin for recycling to the endoplasmic reticulum and refolding or degradation. . |
Accessions | E7EMU6 ENST00000376712.4 A6NP03 Q9NYU1 ENST00000376747.8 [Q9NYU1-1] ENST00000397618.7 ENST00000376714.7 [Q9NYU1-2] |